These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 17444284)

  • 1. Single dose of acetylsalicylic acid in patients with Type 2 diabetes mellitus and/or chronic renal failure ameliorates anaemia by decreasing the rate of neocytolysis.
    Wittmann I; Molnár GA; Wagner L; Köszegi T; Wagner Z; Laczy B; Tamaskó M; Markó L; Mohás M; Nagy J
    Acta Physiol Hung; 2007 Mar; 94(1-2):159-66. PubMed ID: 17444284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes mellitus increases the severity of anemia in non-dialyzed patients with renal failure.
    Ishimura E; Nishizawa Y; Okuno S; Matsumoto N; Emoto M; Inaba M; Kawagishi T; Kim CW; Morii H
    J Nephrol; 1998; 11(2):83-6. PubMed ID: 9589379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neocytolysis contributes to the anemia of renal disease.
    Rice L; Alfrey CP; Driscoll T; Whitley CE; Hachey DL; Suki W
    Am J Kidney Dis; 1999 Jan; 33(1):59-62. PubMed ID: 9915268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of i.v. iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period.
    Silverberg DS; Blum M; Agbaria Z; Deutsch V; Irony M; Schwartz D; Baruch R; Yachnin T; Steinbruch S; Iaina A
    Clin Nephrol; 2001 Mar; 55(3):212-9. PubMed ID: 11316241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythropoietin response to anemia and its association with autonomic neuropathy in type 2 diabetic patients without advanced renal failure.
    Kim MK; Baek KH; Lim DJ; Kim YK; Kang MI; Lee KW; Song KH
    J Diabetes Complications; 2010; 24(2):90-5. PubMed ID: 19303331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Does long-term erythropoietin therapy influence the prevalence of serum markers of hepatitis B and C in haemodialysed uraemic patients?].
    Mesjasz J; Wiecek A; Gonciarz Z; Mazur W; Kokot F
    Pol Merkur Lekarski; 2004 Apr; 16(94):362-7. PubMed ID: 15517934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum erythropoietin concentrations and responses to anaemia in patients with or without chronic kidney disease.
    Artunc F; Risler T
    Nephrol Dial Transplant; 2007 Oct; 22(10):2900-8. PubMed ID: 17556407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and associations of low plasma erythropoietin in patients with Type 2 diabetes mellitus.
    Mojiminiyi OA; Abdella NA; Zaki MY; El Gebely SA; Mohamedi HM; Aldhahi WA
    Diabet Med; 2006 Aug; 23(8):839-44. PubMed ID: 16911620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythropoietin resistance and survival in non-dialysis patients with stage 4-5 chronic kidney disease and heart disease.
    Guerrero-Riscos MÁ; Montes-Delgado R; Seda-Guzmán M; Praena-Fernández JM
    Nefrologia; 2012 May; 32(3):343-52. PubMed ID: 22535158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between insulin resistance and erythropoietin responsiveness in hemodialysis patients.
    Abe M; Okada K; Soma M; Matsumoto K
    Clin Nephrol; 2011 Jan; 75(1):49-58. PubMed ID: 21176750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between erythropoietin responsiveness, insulin resistance, and malnutrition-inflammation-atherosclerosis (MIA) syndrome in hemodialysis patients with diabetes.
    Abe M; Okada K; Maruyama T; Maruyama N; Matsumoto K; Soma M
    Int J Artif Organs; 2011 Jan; 34(1):16-25. PubMed ID: 21298620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of erythropoietin on urinary liver-type fatty-acid-binding protein in patients with chronic renal failure and anemia.
    Nakamura T; Sugaya T; Kawagoe Y; Suzuki T; Ueda Y; Koide H
    Am J Nephrol; 2006; 26(3):276-80. PubMed ID: 16772708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythropoietin deficiency and relative resistance cause anaemia in post-renal transplant recipients with normal renal function.
    Nampoory MR; Johny KV; al-Hilali N; Seshadri MS; Kanagasabhapathy AS
    Nephrol Dial Transplant; 1996 Jan; 11(1):177-81. PubMed ID: 8649630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does autonomic neuropathy play a role in erythropoietin regulation in non-proteinuric Type 2 diabetic patients?
    Spallone V; Maiello MR; Kurukulasuriya N; Barini A; Lovecchio M; Tartaglione R; Mennuni G; Menzinger G
    Diabet Med; 2004 Nov; 21(11):1174-80. PubMed ID: 15498082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anaemia, iron studies and erythropoietin in patients of chronic renal failure.
    Singh NP; Aggarwal L; Singh T; Anuradha S; Kohli R
    J Assoc Physicians India; 1999 Mar; 47(3):284-90. PubMed ID: 10999121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphocyte PC-1 activity in patients on maintenance haemodialysis treated with human erythropoietin and 1-alpha-D3.
    Stefanovic V; Djordjevic V; Ivic M; Mitic-Zlatkovic M; Vlahovic P
    Ann Clin Biochem; 2005 Jan; 42(Pt 1):55-60. PubMed ID: 15802034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential roles of erythropoietin in the management of anaemia and other complications diabetes.
    Khoshdel A; Carney S; Gillies A; Mourad A; Jones B; Nanra R; Trevillian P
    Diabetes Obes Metab; 2008 Jan; 10(1):1-9. PubMed ID: 17645562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect rHuEpo on predialysis CRF patients: study of 45 cases.
    Islam S; Rahman H; Rashid HU
    Bangladesh Med Res Counc Bull; 2005 Aug; 31(2):83-7. PubMed ID: 16967814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous erythropoietin and the association with inflammation and mortality in diabetic chronic kidney disease.
    Wagner M; Alam A; Zimmermann J; Rauh K; Koljaja-Batzner A; Raff U; Wanner C; Schramm L
    Clin J Am Soc Nephrol; 2011 Jul; 6(7):1573-9. PubMed ID: 21734083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythropoietin response to hypoxia in patients with diabetic autonomic neuropathy and non-diabetic chronic renal failure.
    Bosman DR; Osborne CA; Marsden JT; Macdougall IC; Gardner WN; Watkins PJ
    Diabet Med; 2002 Jan; 19(1):65-9. PubMed ID: 11869305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.